Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Sormani

Showing results (41-50 of 390) with videos related to

Pageof 39
Sort By:
Annals of Neurology|March 26, 2011
Comments on "evidence for acute neurotoxicity after chemotherapy"Maria Pia Sormani, Paolo Bruzzi, Gian Luigi Mancardi
Mutation Research|July 18, 2006
Molecular epidemiology: new rules for new tools?Domenico Franco Merlo, Maria Pia Sormani, Paolo Bruzzi
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2020
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatmentsAlice Laroni, Irene Schiavetti, Maria Pia Sormani, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Annals of Neurology|September 6, 2013
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisMaria Pia Sormani, Douglas L Arnold, Nicola De Stefano
Neurology|October 2, 2009
A reassessment of the plateauing relationship between T2 lesion load and disability in MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Annals of Neurology|February 5, 2014
Reply: To PMID 24006277Maria Pia Sormani, Douglas L Arnold, Nicola De Stefano
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2009
Upper respiratory tract infections and sublingual immunotherapy: preliminary evidenceGiorgio Ciprandi, Maria Pia Sormani, Ignazio Cirillo, et al.
Multiple Sclerosis and Related Disorders|September 22, 2022
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysisAngela Albanese, Maria Pia Sormani, Giovanni Gattorno, et al.
Neurology|September 19, 2007
A composite score to predict short-term disease activity in patients with relapsing-remitting MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Pageof 39

Showing results (41-50 of 390) with videos related to

Sort By:
Pageof 39
Annals of Neurology|March 26, 2011
Comments on "evidence for acute neurotoxicity after chemotherapy"Maria Pia Sormani, Paolo Bruzzi, Gian Luigi Mancardi
Mutation Research|July 18, 2006
Molecular epidemiology: new rules for new tools?Domenico Franco Merlo, Maria Pia Sormani, Paolo Bruzzi
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2020
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatmentsAlice Laroni, Irene Schiavetti, Maria Pia Sormani, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Annals of Neurology|September 6, 2013
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisMaria Pia Sormani, Douglas L Arnold, Nicola De Stefano
Neurology|October 2, 2009
A reassessment of the plateauing relationship between T2 lesion load and disability in MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Annals of Neurology|February 5, 2014
Reply: To PMID 24006277Maria Pia Sormani, Douglas L Arnold, Nicola De Stefano
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2009
Upper respiratory tract infections and sublingual immunotherapy: preliminary evidenceGiorgio Ciprandi, Maria Pia Sormani, Ignazio Cirillo, et al.
Multiple Sclerosis and Related Disorders|September 22, 2022
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysisAngela Albanese, Maria Pia Sormani, Giovanni Gattorno, et al.
Neurology|September 19, 2007
A composite score to predict short-term disease activity in patients with relapsing-remitting MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Pageof 39